(Health-NewsWire.Net, May 12, 2017 ) Asia-Pacific Preclinical in-vivo imaging market research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 7.92% to reach USD 174.50 million by 2021, from USD 119.20 million in 2016, which amounts to a cumulative growth of USD 55.3 million.
For full report refer to : http://www.marketdataforecast.com/market-reports/asia-pacific-preclinical-in-vivo-imaging-market-585/
Preclinical imaging (In-VIVO) is mainly used in live animal research for different purposes like drug development. It is further used to monitor treatment response for early indications of efficacy. Technological development of this market provides opportunity for studying disease at molecular level in quantitative way. In vivo imaging acts like a bridge between in vivo clinical research and in vitro exploratory that facilitates fast and direct transfer of preclinical studies from animal models to clinical investigation in humans.
Free Sample of the report is available at : http://www.marketdataforecast.com/market-reports/asia-pacific-preclinical-in-vivo-imaging-market-585/
The report also presents detailed analysis of multitude of factors affecting the Preclinical in-vivo imaging market bearing either positive or negative outcomes. Some of those factors are • growing acceptance of preclinical imaging as a legitimate drug development tool • technological advancements in molecular imaging modalities • challenges associated with the application of radioisotopes, like short half-life of PET radioisotopes
Enquire more about the report at : http://www.marketdataforecast.com/market-reports/asia-pacific-preclinical-in-vivo-imaging-market-585/inquire
For granular level understanding the Preclinical in-vivo imaging market is segmented based on type and application, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Modality market for Preclinical in-vivo imaging market is segmented as optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. Based on Reagent market for Preclinical in-vivo imaging market is segmented as optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents.
To Customize please visit : http://www.marketdataforecast.com/market-reports/asia-pacific-preclinical-in-vivo-imaging-market-585/customize-report
With India and China being the major economies which have unexplored customer base covered in the study the report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific.
To buy the report please go to : <||>rnhttps://www.marketdataforecast.com/cart/buy-now/asia-pacific-preclinical-in-vivo-imaging-market-585
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V.,MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the global preclinical imaging systems market.
The Asia- Pacific Preclinical in-vivo imaging market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of Modality and Reagent along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & microenvironmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Diagnostics Market:
Pyrogen testing Market: http://www.marketdataforecast.com/market-reports/asia-pacific-pyrogen-testing-market-435/
Neurological monitoring devices Market: <||>rnhttp://www.marketdataforecast.com/market-reports/asia-pacific-neurological-monitoring-devices-market-2235/
Point of care diagnostics Market: http://www.marketdataforecast.com/market-reports/asia-pacific-point-of-care-diagnostics-market-1562/
Hemodynamic monitoring devices Market: http://www.marketdataforecast.com/market-reports/asia-pacific-hemodynamic-monitoring-devices-market-1555/
Immunoassays Market: http://www.marketdataforecast.com/market-reports/asia-pacific-immunoassays-market-1571/
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|